TR200201140T2 - İşemik hastalıkların tedavisine veya profilaksisine yönelik ilaç imalatı. - Google Patents

İşemik hastalıkların tedavisine veya profilaksisine yönelik ilaç imalatı.

Info

Publication number
TR200201140T2
TR200201140T2 TR2002/01140T TR200201140T TR200201140T2 TR 200201140 T2 TR200201140 T2 TR 200201140T2 TR 2002/01140 T TR2002/01140 T TR 2002/01140T TR 200201140 T TR200201140 T TR 200201140T TR 200201140 T2 TR200201140 T2 TR 200201140T2
Authority
TR
Turkey
Prior art keywords
manufacture
prophylaxis
medicines
treatment
ischemic diseases
Prior art date
Application number
TR2002/01140T
Other languages
English (en)
Inventor
Weichert Andreas
Albus Udo
Jansen Hans-Willi
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of TR200201140T2 publication Critical patent/TR200201140T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Isbu bulus, isemik durumlarda tedavi ya da korunmaya yönelik bir ilacin imal edilmesi için 2-imidazol-ikameli carbinol'ler (I) ve bunlarin ezacilikta hazmedilen tuzlari ile ilgilidir. Bunlarin içerisinde R1, R2 ve R3 istemlerde belirtilen tanimlara sahiptir.(Formül(I)).
TR2002/01140T 1999-10-27 2000-10-14 İşemik hastalıkların tedavisine veya profilaksisine yönelik ilaç imalatı. TR200201140T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19951701A DE19951701A1 (de) 1999-10-27 1999-10-27 Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten

Publications (1)

Publication Number Publication Date
TR200201140T2 true TR200201140T2 (tr) 2002-11-21

Family

ID=7927020

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01140T TR200201140T2 (tr) 1999-10-27 2000-10-14 İşemik hastalıkların tedavisine veya profilaksisine yönelik ilaç imalatı.

Country Status (30)

Country Link
US (1) US6291502B1 (tr)
EP (1) EP1227811B1 (tr)
JP (1) JP2003512419A (tr)
KR (1) KR20020060213A (tr)
CN (1) CN1188125C (tr)
AR (1) AR026241A1 (tr)
AT (1) ATE257702T1 (tr)
AU (1) AU778836B2 (tr)
BR (1) BR0015024A (tr)
CA (1) CA2388956A1 (tr)
CZ (1) CZ295925B6 (tr)
DE (2) DE19951701A1 (tr)
DK (1) DK1227811T3 (tr)
EE (1) EE200200218A (tr)
ES (1) ES2213621T3 (tr)
HK (1) HK1048938B (tr)
HR (1) HRP20020362A2 (tr)
HU (1) HUP0203213A3 (tr)
IL (1) IL149208A0 (tr)
NO (1) NO20021909L (tr)
NZ (1) NZ518586A (tr)
PL (1) PL355911A1 (tr)
PT (1) PT1227811E (tr)
RU (1) RU2257205C2 (tr)
SK (1) SK5512002A3 (tr)
TR (1) TR200201140T2 (tr)
TW (1) TWI246424B (tr)
WO (1) WO2001030327A2 (tr)
YU (1) YU20902A (tr)
ZA (1) ZA200203035B (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6726829B2 (en) * 1997-04-08 2004-04-27 Scimed Life Systems, Inc. Method of manufacturing a stent
EP1465863B1 (en) 2002-01-04 2008-07-09 NeuroSearch A/S Potassium channel modulators
WO2015175845A1 (en) * 2014-05-15 2015-11-19 Peloton Therapeutics, Inc. Benzimidazole derivatives and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
US4152441A (en) 1972-02-04 1979-05-01 Gist-Brocades N.V. Analgesic imidazolemethanols
BE794940A (fr) * 1972-02-04 1973-08-02 Gist Brocades Nv Nouveaux composes anorexigenes
US5063220A (en) * 1988-10-21 1991-11-05 Syntex Pharmaceuticals, Ltd. Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
US6175013B1 (en) * 1994-06-10 2001-01-16 Eli Lilly And Company Imidazolinyl tachykinin receptor antagonists
KR100365312B1 (ko) 1996-06-27 2003-03-06 얀센 파마슈티카 엔.브이. N-[4-(헤테로아릴메틸)페닐]헤테로아릴아민

Also Published As

Publication number Publication date
YU20902A (sh) 2004-11-25
SK5512002A3 (en) 2002-08-06
DK1227811T3 (da) 2004-04-19
ES2213621T3 (es) 2004-09-01
JP2003512419A (ja) 2003-04-02
RU2257205C2 (ru) 2005-07-27
EE200200218A (et) 2003-06-16
PL355911A1 (en) 2004-05-31
AR026241A1 (es) 2003-02-05
NO20021909D0 (no) 2002-04-23
KR20020060213A (ko) 2002-07-16
CZ20021452A3 (cs) 2002-07-17
ATE257702T1 (de) 2004-01-15
HUP0203213A2 (en) 2003-05-28
US6291502B1 (en) 2001-09-18
CN1188125C (zh) 2005-02-09
EP1227811B1 (de) 2004-01-14
WO2001030327A2 (de) 2001-05-03
PT1227811E (pt) 2004-05-31
NO20021909L (no) 2002-04-23
EP1227811A2 (de) 2002-08-07
WO2001030327A3 (de) 2002-03-14
NZ518586A (en) 2004-07-30
BR0015024A (pt) 2002-06-18
ZA200203035B (en) 2003-03-14
HRP20020362A2 (en) 2004-02-29
AU778836B2 (en) 2004-12-23
HK1048938B (zh) 2005-06-10
IL149208A0 (en) 2002-11-10
HUP0203213A3 (en) 2003-07-28
CN1373663A (zh) 2002-10-09
RU2002113666A (ru) 2004-01-10
AU1138201A (en) 2001-05-08
CZ295925B6 (cs) 2005-11-16
HK1048938A1 (en) 2003-04-25
TWI246424B (en) 2006-01-01
DE50005040D1 (de) 2004-02-19
CA2388956A1 (en) 2001-05-03
DE19951701A1 (de) 2001-05-03

Similar Documents

Publication Publication Date Title
TR200402442T4 (tr) Pirolidin ve piperidin türevleri ve bunların nörodejeneratif bozuklukların tedavisinde kullanımları
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
BR0112395A (pt) Derivados de benzotiazol
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
PT1227820E (pt) Acidos oligossacarido-aldonicos e sua utilizacao topica
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
MX9707453A (es) Derivados de quinazolina.
BR0114913A (pt) Inibidores de metaloproteinase de espiro-pirimidina-2,4,6-triona
TR200101120T2 (tr) Serin proteaz inhibitörü
BR0012901A (pt) Medicamentos de ß - carbolina
TR199800027T1 (tr) Difenilmetilen piperidin türevleri.
SE0202429D0 (sv) Novel Compounds
NO20023362D0 (no) 1,2-diarylbenzimidazoler for behandling av sykdommer assosiert med en mikrogliaaktivering
AR012504A1 (es) Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion.
ATE360428T1 (de) Analgetisches arzneimittel
TR200103457T2 (tr) 4-Fenil-Pirimidin Türevleri.
NO20013414D0 (no) Ny anvendelse av melagatran
TR200201140T2 (tr) İşemik hastalıkların tedavisine veya profilaksisine yönelik ilaç imalatı.
SE0004101D0 (sv) New use
BR9913982A (pt) Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares
NO982863L (no) Nye forbindelser med analgetisk effekt
BR0010699A (pt) Benzimidazóis substituìdos, sua produção e utilização dos mesmos como agente contra protozoários parasitários
TR200102306T2 (tr) Faktör Xa önleyici olarak heterosiklik türevler.
PT1411956E (pt) Utilizacao de polissacaridos sobre-sulfatados como inibidores de vih
BR0214104A (pt) Oligopeptìdeos e composições contendo os mesmos como inibidores de catepsina